Lithium Ion

Lithium Ion

SCHEMBL702592

Cn1cc(CN[C@@H]2CC3CCN2CC3)c2c(C(=O)[O-])cccc21.[Li+]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
PARP1 P09874 4/20 0.33
PARP2 Q9UGN5 3/20 0.33
CDK2 P24941 1/20 0.33
HTR2A P28223 2/20 0.32
HTR2C P28335 2/20 0.32
HTR2B P41595 2/20 0.32
USP2 O75604 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
CTSG P08311 1/20 0.31
CMA1 P23946 1/20 0.31
GAA P10253 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL701025 0.90 CDK2 (0.37) KDM4EPARP1PARP2CDK2HTR2A
SCHEMBL701546 0.88 NR4A2 (0.39) KDM4EPARP1PARP2USP2SMN1; SMN2
Lithium Ion SCHEMBL699921 0.71 HTR3A (0.42) CDK2
Lithium Ion SCHEMBL700016 0.71 CHRM2 (0.46) HTR2AHTR2C
Lithium Ion SCHEMBL703148 0.71 CHRM2 (0.46) HTR2AHTR2C
SCHEMBL701026 0.68 CHRM2 (0.49) HTR2AHTR2CGAA
SCHEMBL701024 0.68 CHRM2 (0.49) HTR2AHTR2CGAA
SCHEMBL705001 0.67 CHRM2 (0.48) HTR2AHTR2CGAA
SCHEMBL701547 0.67 CHRM2 (0.50) HTR2AHTR2CGAA
SCHEMBL701545 0.67 CHRM2 (0.50) HTR2AHTR2CGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124600-B2 5-HT3 receptor modulators, methods of making, and use thereof ALBANY MOLECULAR RESEARCH, INC. (US) 2012-02-28 US disclosed
EP-2310019-A2 5-HT3 RECEPTOR MODULATORS, METHODS OF MAKING, AND USE THEREOF Albany Molecular Research, Inc. (US) 2011-04-20 EP disclosed